skip to content
WHO Drug Information Vol. 28 No. 1 2014. Preview this item
ClosePreview this item
Checking...

WHO Drug Information Vol. 28 No. 1 2014.

Author: World Health Organization
Publisher: Geneva : World Health Organization, 2014.
Edition/Format:   eBook : Document : English
Summary:
WHO Drug Information communicates pharmaceutical information that is either developed and issued by WHO or transmitted to WHO by research and regulatory agencies throughout the World. The journal also includes regular presentations of newly proposed and recommended International Nonproprietary Names (INN) for Pharmaceuticals Substances. This volume contains the recommended INN List No. 71.
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Periodicals
Additional Physical Format: Print version:
Organization, World Health.
WHO Drug Information Vol. 28 No. 1 2014.
Geneva : World Health Organization, ©2014
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: World Health Organization
ISBN: 9789240692855 9240692851
OCLC Number: 888748998
Notes: Droxidopa approved for neurogenic orthostatic hypotension.
Description: 1 online resource (124 pages)
Contents: Cover; Contents; Regulatory harmonization; The International Generic Drug Regulators Pilot; Introduction; Exploratory meeting; Preliminary surveys; The path forward; Operating procedures; Progress to date; Decentralised Procedure as a model for cooperation; Some observations; Conclusion; References; WHO support for medicines regulatory harmonization in Africa: focus on East African Community; The African Medicines Registration Harmonization initiative; The role of Regional Economic Communities; The EAC Medicines Registration Harmonization project; NMRA assessments. Progress towards harmonized registrationCollaboration with other initiatives; Conclusion; References; Technologies, standards and norms; Standards for biological products; Biotherapeutic products; Adjuvanted vaccines; Typhoid conjugate vaccines; Reference preparations; References; Safety and efficacy issues; Combined hormonal contraceptives and venous thromboembolism; Clobazam: serious skin reactions; Amiodarone: pulmonary toxicity; Methylphenidate: rare risk of long-lasting erections in males; Glibenclamide: risk of hypoglycaemia in elderly and renal-impaired patients. Subcutaneous epoetin alfa: contraindicated in Singapore in chronic kidney disease patientsAcipimox: only to be used as additional or alternative treatment; Estradiol-containing creams: new restrictions; Clopidogrel: rare reports of acquired haemophilia; Sodium phosphate products in high doses: severe dehydration; Emergency contraceptives --
high bodyweight may reduce effectiveness; Testosterone: possible risk of stroke and heart attack; Lithium: hypercalcaemia and hyperparathyroidism; Saxagliptin: possible risk of heart failure. Strontium ranelate: further restrictions due to cardiovascular risksMethysergide-containing medicines: new restrictions; Regulatory action and news; Regulatory options in the fight against antimicrobial resistance; EMA and FDA collaborate on bioequivalence inspections; Tafenoquine receives FDA Breakthrough Therapy designation; Regulatory action against Ranbaxy's Toansa facility; WHO response to FDA findings at Ranbaxy's Toansa site; New partnership to strengthen regulatory systems; Canada-US Common Electronic Submissions Gateway. Updated guidance for annual strain change of seasonal influenza vaccinesEMA and FDA strengthen collaboration on pharmacovigilance; European Medicines Agency publishes first summary of a risk-management plan for a medicine; EMA and FDA extend parallel assessment pilot; Australia and New Zealand harmonization activities; Approvals; First adjuvanted vaccine for H5N1 avian influenza approved; Umeclidinium and vilanterol approved for chronic obstructive pulmonary disease; Dapaglifozin approved for type 2 diabetes; Trametinib and dabrafenib approved in combination for advanced melanoma.

Abstract:

WHO Drug Information communicates pharmaceutical information that is either developed and issued by WHO or transmitted to WHO by research and regulatory agencies throughout the World. The journal also includes regular presentations of newly proposed and recommended International Nonproprietary Names (INN) for Pharmaceuticals Substances. This volume contains the recommended INN List No. 71.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/888748998> # WHO Drug Information Vol. 28 No. 1 2014.
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
   library:oclcnum "888748998" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/sz> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/2057727813#Place/geneva> ; # Geneva
   schema:about <http://experiment.worldcat.org/entity/work/data/2057727813#Topic/pharmaceutical_industry> ; # Pharmaceutical industry
   schema:about <http://dewey.info/class/615.105/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/2057727813#Topic/drugs_standards> ; # Drugs--Standards
   schema:about <http://experiment.worldcat.org/entity/work/data/2057727813#Topic/pharmaceutical_preparations_standards> ; # Pharmaceutical preparations--Standards
   schema:bookFormat schema:EBook ;
   schema:creator <http://experiment.worldcat.org/entity/work/data/2057727813#Person/organization_world_health> ; # World Health Organization
   schema:datePublished "2014" ;
   schema:description "WHO Drug Information communicates pharmaceutical information that is either developed and issued by WHO or transmitted to WHO by research and regulatory agencies throughout the World. The journal also includes regular presentations of newly proposed and recommended International Nonproprietary Names (INN) for Pharmaceuticals Substances. This volume contains the recommended INN List No. 71."@en ;
   schema:description "Cover; Contents; Regulatory harmonization; The International Generic Drug Regulators Pilot; Introduction; Exploratory meeting; Preliminary surveys; The path forward; Operating procedures; Progress to date; Decentralised Procedure as a model for cooperation; Some observations; Conclusion; References; WHO support for medicines regulatory harmonization in Africa: focus on East African Community; The African Medicines Registration Harmonization initiative; The role of Regional Economic Communities; The EAC Medicines Registration Harmonization project; NMRA assessments."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/2057727813> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://worldcat.org/entity/work/data/2057727813#CreativeWork/who_drug_information_vol_28_no_1_2014> ;
   schema:name "WHO Drug Information Vol. 28 No. 1 2014."@en ;
   schema:productID "888748998" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/888748998#PublicationEvent/geneva_world_health_organization_2014> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/2057727813#Agent/world_health_organization> ; # World Health Organization
   schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=1769051> ;
   schema:workExample <http://worldcat.org/isbn/9789240692855> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/888748998> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2057727813#Agent/world_health_organization> # World Health Organization
    a bgn:Agent ;
   schema:name "World Health Organization" ;
    .

<http://experiment.worldcat.org/entity/work/data/2057727813#Person/organization_world_health> # World Health Organization
    a schema:Person ;
   schema:familyName "Organization" ;
   schema:givenName "World Health" ;
   schema:name "World Health Organization" ;
    .

<http://experiment.worldcat.org/entity/work/data/2057727813#Topic/pharmaceutical_industry> # Pharmaceutical industry
    a schema:Intangible ;
   schema:name "Pharmaceutical industry"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2057727813#Topic/pharmaceutical_preparations_standards> # Pharmaceutical preparations--Standards
    a schema:Intangible ;
   schema:name "Pharmaceutical preparations--Standards"@en ;
    .

<http://worldcat.org/entity/work/data/2057727813#CreativeWork/who_drug_information_vol_28_no_1_2014>
    a schema:CreativeWork ;
   rdfs:label "WHO Drug Information Vol. 28 No. 1 2014." ;
   schema:description "Print version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/888748998> ; # WHO Drug Information Vol. 28 No. 1 2014.
    .

<http://worldcat.org/isbn/9789240692855>
    a schema:ProductModel ;
   schema:isbn "9240692851" ;
   schema:isbn "9789240692855" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.